// App-Quantinova.ai

2135 : Estrogen receptor-beta and mutant p53 signaling crosstalk as a novel molecular target to overcome therapeutic resistance in high-grade serous ovarian cancer

Researchers

Presenter

  • Chetan C. Oturkar

Principal Investigators

  • Gokul M. Das

Medical Centers

  • Roswell Park Cancer Institute, Buffalo, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • High grade serous ovarian cancer

  • High-grade serous carcinoma

  • Ovarian cancer

  • Gynaecological cancer

  • Solid malignancies

Biomarkers

  • Forkhead box M1

Drug/Treatment

  • Carboplatin

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved